Survivorship and Effectiveness of the Ortho Development® Entrada™ Hip System for Total Hip Arthroplasty

Part of paid clinical trials in Portland, Oregon.

Sponsor
Ortho Development Corporation
Study ID
NCT04277416
Status
Enrolling By Invitation

Conditions

  • Total Hip Arthroplasty
  • Total Hip Replacement

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Total Hip Arthroplasty — DEVICE
    To evaluate Implant survival based on removal or intended removal of any component of the Entrada™ Hip System at five years of follow-up.

Study Details

To evaluate Implant survival based on removal or intended removal of any component of the Entrada™ Hip System at five years of follow-up.

Key Dates

First listed
Feb 20, 2020
Start date
Feb 28, 2020
Status verified
Oct 2022
Primary completion
Dec 31, 2031
Completion
Dec 31, 2032

Study Design

Enrollment
250 participants (estimated)

Arms

  • Arm: Entrada Hip System
    All orthopaedic patients that are scheduled to undergo primary total hip arthroplasty using the Entrada™ Hip System within 12 weeks will be screened for the following eligibility criteria.

Primary Outcome Measure

Implant Survival [ Time Frame: 5 - 10-year follow-up ]

Locations (1)

FacilityCityStateZIPSite coordinators
Oregon Health Sciences UniversityPortlandOregon97239-

Find similar trials in Portland, OR

By research site
Oregon Health Sciences University· Portland, OR

Related Studies